Project Grant R33DA065192
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded $4.63 million to The Research Foundation for the State University of New York (SUNY Downstate Health Sciences University) under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct longitudinal research examining the intersection of neighborhood conditions, neural circuits, and substance use disorder (SUD) behaviors across the early life course. The project, which commenced on September 30, 2025, and...
- Federal Grant Award Summary New York University received a $1.5M Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), effective September 1, 2025 through May 31, 2030. The research initiative examines the impacts of New Mexico House Bill 139 (HB-139), which eliminated court fees and surcharges in 2024, on substance use outcomes and criminal justice engagement. The study leverages HB-139 as a natural experiment to...
- Federal Project Grant Award Summary New York University School of Medicine received a $1.45 million Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), effective July 1, 2025, through March 31, 2030. This research project will characterize complex opioid use disorder (OUD) care trajectories and outcomes following acute service utilization through a population-based data linkage study. The primary deliverable is...
- Federal Project Grant Award Summary New York University has been awarded $201,250 by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) for a two-year project period from June 1, 2025, through May 31, 2027. This Project Grant supports basic neuroscience research investigating the synaptic organization of cholinergic interneurons in the nucleus accumbens, a brain region critical to motivated behaviors and implicated in substance use...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded $781,032 to The Research Foundation for the State University of New York (RF SUNY) on August 1, 2025, under the Drug Use and Addiction Research Programs (CFDA 93.279) to support a five-year research project through April 30, 2030. This Project Grant funds fundamental neuroscience research investigating the interplay between limbic norepinephrine (NE) and dopamine (DA) circuits and their role in sex differences in...
- Federal Grant Award Summary The National Institute on Drug Abuse awarded a $159,615 Project Grant to Icahn School of Medicine at Mount Sinai on July 15, 2025, under the Drug Use and Addiction Research Programs (CFDA 93.279). The grant supports research titled "Predicting Craving and Relapse Using Neurobehavioral Markers of Goals and Habits in Opioid Use Disorder," which addresses the critical public health challenge of opioid overdose deaths exceeding 100,000 annually in 2022. The...
- Federal Project Grant Award Summary Addinex Technologies, Inc. received a $613,056 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop and refine a medication adherence and monitoring system for decentralized clinical trials in substance use disorder (SUD) treatment. The award, effective September 1, 2025, through August 31, 2026, supports the adaptation of Addinex's existing medication management platform...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded Columbia University $500,014 under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop and test WINGS+++, an integrated mobile health intervention designed to address the intersection of opioid use disorder (OUD), substance use disorders (SUD), intimate partner violence (IPV), and post-traumatic stress disorder (PTSD) among women. The project, initiated September 1, 2025, and concluding August 31,...
- Federal Project Grant Award Summary Yale University was awarded $688,271 by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) beginning June 1, 2025, with a completion date of February 28, 2030. The award supports a multiple-methods research initiative examining spatial and temporal variability in Connecticut's illicit drug market in response to the fourth wave of the opioid overdose crisis. The project will deliver integrated data...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded $3.1 million under the Drug Use and Addiction Research Programs (CFDA 93.279) to the University of Massachusetts Medical School to conduct a hybrid trial testing the effectiveness of Jail ECHO Operations, Planning, and Strategy (J-ECHO OPS)—an implementation strategy designed to increase access to medication for opioid use disorder (MOUD) in rural jails. The award, effective September 1, 2025, through May 31, 2030,...
The National Institute on Drug Abuse (NIDA) awarded $1,091,599 to the Research Foundation For Mental Hygiene, Inc. (operating as the New York State Psychiatric Institute) on March 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop and implement E-ConnectYA, a tailored intervention system designed to address overdose risk, suicide, and behavioral health problems among young adults involved in the criminal legal system (YACL). The five-year project, concluding January 31, 2031, adapts an existing evidence-based intervention model to integrate overdose risk screening and peer support services, capitalizing on a nationwide employment training program to engage this hard-to-reach population and improve identification of substance use and mental health treatment needs. The research deliverables include adaptation of the E-Connect intervention model to create E-ConnectYA (Aim 1) and execution of a Type 1 Hybrid Effectiveness-Implementation stepped-wedge trial design across multiple Community Employment Options (CEO) sites to evaluate treatment referral rates and service uptake among YACL (Aims 2-3). This implementation science study leverages the General Partnerships Model and Exploration, Preparation, Implementation, Sustainment (EPIS) frameworks to systematically test whether integrating behavioral health screening and peer support into employment services increases treatment engagement for substance use and mental health conditions among probation and parole-involved young adults.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $1.1m | 2/17/26 |